MedWatch

Lundbeck Chairman: not many potential replacements for Kåre Schultz

Lundbeck's Board of Directors wants the company's new CEO to have with experience the company's own area of focus, illnesses in the central nervous system, however this requirement makes the search for Kåre Schultz's replacement more complicated.

Foto: Niels Hougaard

The search for Kåre Schultz's replacement is still in full swing at Lundbeck, which has been without a CEO since the end of October last year.

However, it is not easy to find a replacement for the previous CEO, who left Lundbeck to go to Israeli Teva. According to Chairman of the Board, Lars Rasmussen, Lundbeck's focus on illnesses in the central nervous system complicates the search for a new CEO.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Nye insulintilskud bekymrer Diabetesforeningen

Diabetesforeningen er utilfredse med Medicintilskudsnævnets indstilling til en revurdering af tilskud for diabetesmidler, som patientforeningen anser som en spareøvelse uden hensyntagen til patienterne.

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier